2018
DOI: 10.21823/2311-2905-2018-24-4-20-31
|View full text |Cite
|
Sign up to set email alerts
|

Adverse Trends in the Etiology of Orthopedic Infection: Results of 6-Year Monitoring of the Structure and Resistance of Leading Pathogens

Abstract: Osteomyelitis remains one of the most intractable diseases. The nature of the pathogen and its resistance to antibiotics significantly affect the outcome and cost of treatment.The aim of the study: to analyze the dynamics of the spectrum and antibiotic resistance of the leading pathogens of orthopedic infection for the period 2012– 2017.Material and methods. The structure of pathogens isolated from the focus of infection from 2774 patients with periprosthetic infection and chronic osteomyelitis was retrospecti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
1
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 27 publications
(5 citation statements)
references
References 26 publications
1
1
0
3
Order By: Relevance
“…Multi-resistance to fluoroquinolones of the third and fourth generations was a feature of this microorganism group. Similar trends were detected during 6-year monitoring of the structure and resistance of the leading pathogens [39].…”
Section: Discussionsupporting
confidence: 79%
“…Multi-resistance to fluoroquinolones of the third and fourth generations was a feature of this microorganism group. Similar trends were detected during 6-year monitoring of the structure and resistance of the leading pathogens [39].…”
Section: Discussionsupporting
confidence: 79%
“…В связи с тенденцией к увеличению количества резистентных штаммов бактерий [21,22,23], наблюдаемой в настоящее время, появляется активный интерес к фаготерапии не только в Восточной Европе, России, Грузии и Польше [24, 25,26,27], но и в странах Западной Европы и Америки [11], где пока ни один терапевтический фаговый препарат не был одобрен нормативно-правовой базой для использования человеком [28,29]. В РФ бактериофаги зарегистрированы как лекарственный препарат, что даёт нам право их использовать при лечении бактериальной инфекции.…”
Section: Discussionunclassified
“…Currently, an increase in the occurrence of antibiotic-resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus epidermidis (MRSE), and vancomycin-resistant Enterococci (VRE) [ 1 , 2 , 3 ], exacerbates the PJI problem and is associated with the worsening of treatment outcomes [ 4 , 5 , 6 ]. The ability of staphylococci and their methicillin-resistant strains to produce lipopolysaccharide biofilms at their adhesion sites, decreases the delivery of antibacterial therapeutic agents to the inflammatory site due to the barrier properties of the bacterial biofilm, thus requiring a significant increase in the minimum inhibitory concentration of antibiotics [ 7 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%